Position in DHR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,428
-$8,896 QoQ
Shares Held
18
-72.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2,053
of 2,094 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Rakuten Securities, Inc. holds $104,029 across 10 Diagnostics & Research names. DHR ranks #5 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
130 | $35,288 | |
| 2 | ILMN |
Illumina, Inc.
|
185 | $32,528 | |
| 3 | GH |
Guardant Health, Inc.
|
101 | $15,153 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
21 | $11,055 | |
| 5 | DHR |
Danaher Corp /De/
This page
|
18 | $3,428 | |
| 6 | TMO |
Thermo Fisher Scientific Inc.
|
6 | $3,008 | |
| 7 | LH |
Labcorp Holdings Inc.
|
6 | $1,680 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
5 | $966 |
All Filings in DHR
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,428 | 18 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $12,324 | 65 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $13,735 | 60 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $29,342 | 148 | Shares | Defined | 2025-10-28 | |
| 2025-06-30 | $12,642 | 64 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $45,920 | 224 | Shares | Defined | 2025-04-18 | |
| 2024-12-31 | $38,564 | 168 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $9,730 | 35 | Shares | Defined | 2024-11-05 | |
| 2024-06-30 | $16,490 | 66 | Shares | Defined | 2024-07-31 | |
| 2024-03-31 | $60,681 | 243 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $35,626 | 154 | Shares | Defined | 2024-01-31 | |
| No filing history on record for this holder in this stock. | ||||||